Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003500 |
---|---|
Receipt number | R000004243 |
Scientific Title | Multicenter Phase II Study of XELOX with Bevacizumab in the Late Elderly Patients with Unresectable Advanced/Recurrent Colorectal Cancer |
Date of disclosure of the study information | 2010/04/16 |
Last modified on | 2018/09/20 08:22:01 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/04/16 22:41:22 | ||
2 | Update | 2015/12/01 16:49:09 | UMIN ID1 |
|
3 | Update | 2015/12/02 14:41:57 | Key inclusion criteria Key exclusion criteria |
|
4 | Update | 2015/12/02 16:19:29 | Organization Organization Address Address TEL Address Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2015/12/02 16:49:14 | Recruitment status Publication of results Results Other related information |
|
6 | Update | 2016/04/04 16:02:38 | Name of primary person or sponsor Organization |
|
7 | Update | 2017/04/25 19:45:33 | Other related information Other related information |
|
8 | Update | 2018/09/20 08:22:02 | Recruitment status Other related information |